Results 1 to 10 of about 84,832 (141)

Understanding injecting drug use in Afghanistan: A scoping review [PDF]

Substance Abuse Treatment, Prevention, and Policy, 2022
Background Several reports have described a growing prevalence of illicit drug use in Afghanistan, with recognition of a recent shift from traditional modes of consumption involving inhalation and oral ingestion to injecting drug use. Objective Conduct a
Frishta Nafeh, Sufiat Fusigboye, Bundit Sornpaisarn   +2 more
doaj   +2 more sources

Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study [PDF]

Viruses, 2022
Background: New technologies and therapies allow the possibility of a single-visit test and treat model for hepatitis C virus (HCV), addressing some of the barriers to care faced by people who inject drugs.
Anna Conway, Phillip Read, Rosie Gilliver, Tony McNaughton, Heather Valerio, Evan B. Cunningham, Charles Henderson, Brett Hadlow, Katrina Molloy, Anna Doab, Shane Tillakeratne, Lucy Pepolim, Mary Ellen Harrod, Gregory J. Dore, Jason Grebely   +14 more
doaj   +2 more sources

Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use [PDF]

Harm Reduction Journal, 2018
Background Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention initiative. Elevated opioid overdose risk following prison release means release from custody provides an ideal opportunity for THN initiatives.
Michael Curtis, Paul Dietze, Campbell Aitken, Amy Kirwan, Stuart A. Kinner, Tony Butler, Mark Stoové   +6 more
doaj   +2 more sources

Changing age profile and incidence of injecting drug use initiation among people in Australia who inject drugs: evidence from two national repeated cross-sectional studiesResearch in context [PDF]

The Lancet Regional Health. Western Pacific
Summary: Background: The age of people who inject drugs appears to be increasing in some high-income countries. We aimed to explore trends in the age of people injecting and recently starting to inject drugs in Australia, and to model incidence of ...
Olivia Price, Lisa Maher, Amy Peacock, Farzaneh Zolala, Louisa Degenhardt, Paul Dietze, Sarah Larney, Seraina Agramunt, Samantha Colledge-Frisby, Bradley Mathers, Dan Lewer, Rachel Sutherland   +11 more
doaj   +2 more sources

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial [PDF]

Health Science Reports, 2020
Background and Aims Direct‐acting antiviral therapy for hepatitis C virus (HCV) is effective, but few prospective studies among people with ongoing injecting drug use exist.
Jason Grebely, Phillip Read, Evan B. Cunningham, Martin Weltman, Gail V. Matthews, Adrian Dunlop, Mark Montebello, Marianne Martinello, Rosie Gilliver, Philippa Marks, Tanya L. Applegate, Gregory J. Dore, the DARLO‐C Study Group   +12 more
doaj   +2 more sources

Feasibility and acceptability of multiple methods of recording injecting drug use episode data among people who inject drugs in Melbourne, Australia: a pilot evaluation study protocol [PDF]

BMJ Open
Introduction Opioid overdose and blood-borne virus transmission are key health risks for people who inject drugs. Existing study methods that record data on injecting drug risks mostly rely on retrospective self-reporting that, while valid, are limited ...
Alexis Roth, Peter Higgs, Paul Dietze, Nick Scott, Daniel O’Keefe, Filip Djordjevic, Ashleigh Cara Stewart, Dylan Vella-Horne, Zoe Gleeson, Damian Pavlyshyn, Matthew Gill, Rebekka Petrovic, Ben Cocchiaro   +12 more
doaj   +2 more sources

The associations of poor psychiatric well-being among incarcerated men with injecting drug use histories in Victoria, Australia [PDF]

Health & Justice, 2018
Background Dual substance dependence and psychiatric and psychological morbidities are overrepresented in prison populations and associated with reoffending.
Reece Cossar, Mark Stoové, Stuart A. Kinner, Paul Dietze, Campbell Aitken, Michael Curtis, Amy Kirwan, James R. P. Ogloff   +7 more
doaj   +2 more sources

Infectious Complications in Injection Drug Use [PDF]

MedEdPORTAL, 2021
The prevalence of opioid use disorder has increased steadily over the last decade (from 2.2 million in 2010 to 10.2 million in 2018) and with it, a surge in infectious complications associated with injection drug use (IDU). Trainees in internal medicine routinely diagnose, manage, and treat patients experiencing these infections in the hospital setting
Ryan Knodle, Lindsay Demers, Rachel Simmons   +2 more
openaire   +3 more sources

Pregnancy and injecting drug use [PDF]

BMJ, 2008
Injecting drug use has adverse effects on pregnancy and perinatal outcomes. Methadone treatment improves birth rate but carries a risk of neonatal abstinence syndrome; withdrawal of methadone during pregnancy is not ...
James, Bell, Lucy, Harvey-Dodds
openaire   +2 more sources

Botulism due to Injection Drug Use

Journal of Education and Teaching in Emergency Medicine, 2023
This scenario was developed to educate emergency medicine residents on the diagnosis and management of wound botulism secondary to injection drug use.Botulism is a relatively rare cause of respiratory failure and descending weakness in the United States, caused by prevention of presynaptic acetylcholine release at the neuromuscular junction.
Hoffman, Timothy, Yee, Jennifer
openaire   +4 more sources